Emerging Clinical Activity of REGN1979, an Anti-CD20 x Anti-CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Follicular Lymphoma (FL), Diffuse Large B-Cell Lymphoma (DLBCL), and Other B-Cell Non-Hodgkin Lymphoma (B-NHL) Subtypes

被引：12

作者：

Bannerji, Rajat ^{[1
]}

Arnason, Jon E. ^{[2
]}

Advani, Ranjana ^{[3
]}

Brown, Jennifer R. ^{[4
]}

Allan, John N. ^{[5
]}

Ansell, Stephen M. ^{[6
]}

Barnes, Jeffrey ^{[7
]}

O'Brien, Susan M. ^{[8
]}

Chavez, Julio C. ^{[9
]}

Duell, Johannes ^{[10
]}

Lowy, Israel ^{[11
]}

Charnas, Robert ^{[11
]}

Sternberg, David ^{[11
]}

Ambati, Srikanth ^{[11
]}

Adriaens, Lieve ^{[12
]}

Ufkin, Melanie ^{[11
]}

Yan, Xiaoyu ^{[11
]}

Li, Jingjin ^{[12
]}

Navarro, Mark ^{[11
]}

Gasparini, Peter ^{[11
]}

Jankovic, Vladimir ^{[11
]}

Fiaschi, Nathalie ^{[11
]}

Zhang, Wen ^{[11
]}

Hamon, Sara ^{[11
]}

Thurston, Gavin ^{[11
]}

Topp, Max S. ^{[10
]}

机构：

[1] Canc Inst New Jersey, New Brunswick, NJ USA

[2] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA

[3] Stanford Univ, Stanford, CA 94305 USA

[4] Dana Farber Canc Inst, Boston, MA 02115 USA

[5] Weill Cornell Med, Div Hematol & Oncol, New York, NY USA

[6] Mayo Clin, Div Hematol, Rochester, MN USA

[7] Massachusetts Gen Hosp, Boston, MA 02114 USA

[8] Univ Calif Irvine, Irvine, CA USA

[9] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA

[10] Univ Hosp Wurzburg, Wurzburg, Germany

[11] Regeneron Pharmaceut Inc, Tarrytown, NY USA

[12] Regeneron Pharmaceut Inc, Basking Ridge, NJ USA

来源：

BLOOD | 2018年 / 132卷

关键词：

D O I：

10.1182/blood-2018-99-113328

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1690

引用

页数：5

共 50 条

[41] Phase I study of bendamustine combined with rituximab in relapsed or refractory aggressive B-cell non-Hodgkin lymphoma (B-NHL)
Taniwaki, M.
Ogura, M.
Matsumoto, Y.
Uchida, T.
Ohmachi, K.
Ando, K.
Watanabe, T.
Tobinai, K.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[42] Treatment of B cell low grade non-Hodgkin's lymphoma (NHL) with anti-CD20 monoclonal antibody Rituximab®
Federico, M
Clo, V
Vinci, G
Sacchi, S
ANNALS OF ONCOLOGY, 1998, 9 : 32 - 32
[43] Phase I dose escalation of ibrutinib and buparlisib in relapsed/refractory diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL), and follicular lymphoma (FL).
Batlevi, Connie Lee
Hamlin, Paul A.
Matasar, Matthew J.
Horwitz, Steven M.
Gerecitano, John F.
Moskowitz, Craig H.
Straus, David J.
Zelenetz, Andrew David
Drullinsky, Pamela
Copeland, Amanda
Ahsanuddin, Salma
Callan, Devin
Freidin, Benjamin
Porzio, Robert
Dang, Thu Oanh
Ni, Ai
Rademaker, Jurgen
Schoder, Heiko
Dogan, Ahmet
Younes, Anas
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[44] Retrospective Study of CD20 Expression Loss in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
Marshalek, Joseph P.
Qing, Xin
Dragan, Marcin
Tomassetti, Sarah
JOURNAL OF HEMATOLOGY, 2024, 13 (06) : 268 - 277
[45] Clinical Impact of the Presence of a Diffuse Large B-Cell Lymphoma (DLBCL) Component in the Outcome of Untreated Patients with Follicular Lymphoma (FL)
Magnano, Laura
Dlouhy, Ivan
Balague, Olga
Rivas-Delgado, Alfredo
Rovira, Jordina
Karube, Kennosuke
Gonzalez, Blanca
Martinez-Trillos, Alejandra
Martinez, Antonio
Delgado, Julio
Gine, Eva
Villamor, Neus
Campo, Elias
Lopez-Guillermo, Armando
BLOOD, 2016, 128 (22)
[46] Guideline for radioimmunotherapy of CD20+ follicular B-cell non-Hodgkin's lymphoma
Fischer, M.
Gruenwald, F.
Knapp, W. H.
Truemper, L.
von Schilling, C.
Dreyling, M.
NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2009, 48 (06): : 215 - 220
[47] RADIOIMMUNOTHERAPY OF B-CELL LYMPHOMA WITH [I-131] ANTI-B1 (ANTI-CD20) ANTIBODY
KAMINSKI, MS
ZASADNY, KR
FRANCIS, IR
MILIK, AW
ROSS, CW
MOON, SD
CRAWFORD, SM
BURGESS, JM
PETRY, NA
BUTCHKO, GM
GLENN, SD
WAHL, RL
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (07) : 459 - 465
[48] Phase 1 Study of REGN1979, an Anti-CD20 x Anti-CD3 Bispecific Monoclonal Antibody, in Patients with CD20+B-Cell Malignancies Previously Treated with CD20-Directed Antibody Therapy
Bannerji, Rajat
Brown, Jennifer R.
Advani, Ranjana H.
Arnason, Jon
O'Brien, Susan M.
Allan, John N.
Chavez, Julio C.
Barnes, Jeffrey A.
Joyce, Robin
Ansell, Stephen
Topp, Max S.
Adriaens, Lieve
Ufkin, Melanie
Kostic, Ana
Paccaly, Anne
Gao, Bo
Trail, Pamela A.
Lowy, Israel
Brownstein, Carrie
BLOOD, 2016, 128 (22)
[49] Characterization of a humanized anti-CD20 antibody with potent antitumor activity against B-cell lymphoma
Wu, Lan
Wang, Chong
Zhang, Dapeng
Zhang, Xunming
Qian, Weizhu
Zhao, Lei
Wang, Hao
Li, Bohua
Guo, Yajun
CANCER LETTERS, 2010, 292 (02) : 208 - 214
[50] Prognostic impact of CD38 expression in relapsed or refractory diffuse large B-cell lymphoma and follicular lymphoma transformation
Wada, Fumiya
Shimomura, Yoshimitsu
Kamijo, Kimimori
Yamashita, Daisuke
Ohno, Aya
Himeno, Mayuko
Maruoka, Hayato
Hara, Shigeo
Ishikawa, Takayuki
LEUKEMIA & LYMPHOMA, 2022, 63 (06) : 1484 - 1487

← 1 2 3 4 5 →